Anthera Pharmaceuticals Inc 4
4 · Anthera Pharmaceuticals Inc · Filed Jan 2, 2015
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Award
Stock option (right to buy)
2014-12-30+120,000→ 120,000 totalExercise: $1.61Exp: 2024-12-30→ Common Stock (120,000 underlying) - Gift
Common Stock
2014-12-30−1,364→ 9,101 total
Footnotes (2)
- [F1]On December 31, 2014, the Reporting Person transferred 1,364 shares to the Debra A. Odink Living Trust.
- [F2]This stock option vests monthly over four years beginning December 30, 2014 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start and will expire on December 30, 2024.